Principal references:

  • Kroemer G, Dallaporta B, Resche-Rigon M. The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol. 1998;60:619-42.
  • Zamzami N, Kroemer G. The mitochondrion in apoptosis: how Pandora's box opens. Nat Rev Mol Cell Biol. 2001 Jan;2(1):67-71.
  • Zhivotovsky B, Kroemer G. Apoptosis and genomic instability. Nat Rev Mol Cell Biol. 2004 Sep;5(9):752-62. Kroemer G, Jäättelä M. Lysosomes and autophagy in cell death control. Nat Rev Cancer. 2005 Nov;5(11):886-97. Faivre S, Kroemer G, Raymond E. Current development of mTOR inhibitors as anticancer agents. Nat Rev Drug Discov. 2006 Aug;5(8):671-88.
  • Zitvogel L, Tesniere A, Kroemer G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol. 2006 Oct;6(10):715-27.
  • Maiuri MC, Zalckvar E, Kimchi A, Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol. 2007 Sep;8(9):741-52.
  • Zitvogel L, Apetoh L, Ghiringhelli F, Kroemer G. Immunological aspects of chemotherapy. Nat Rev Immunol. 2008 Jan;8(1):59-73.
  • Kroemer G, Levine B. Autophagic cell death: the story of a misnomer. Nat Rev Mol Cell Biol. 2008 Dec;9(12):1004-10.
  • Green DR, Ferguson T, Zitvogel L, Kroemer G. Immunogenic and tolerogenic cell death. Nat Rev Immunol. 2009 May;9(5):353-63.
  • Galluzzi L, Blomgren K, Kroemer G. Mitochondrial membrane permeabilization in neuronal injury. Nat Rev Neurosci. 2009 Jul;10(7):481-94.
  • Fulda S, Galluzzi L, Kroemer G. Targeting mitochondria for cancer therapy. Nat Rev Drug Discov. 2010 Jun;9(6):447-64.
  • Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol. 2010 Oct;11(10):700-14.
  • Kepp O, Galluzzi L, Yuan J, Kroemer G. Cell death assays for drug discovery. Nat Rev Drug Discov. 2011 Mar;10(3):221-37.
  • Zitvogel L, Kepp O, Kroemer G. Immune parameters affecting the efficacy of chemotherapeutic regimens. Nat Rev Clin Oncol. 2011 Mar;8(3):151-60.
  • Vitale I, Galluzzi L, Castedo M, Kroemer G. Mitotic catastrophe: a mechanism for avoiding genomic instability. Nat Rev Mol Cell Biol. 2011 Jun;12(6):385-92.
  • Galluzzi L, Senovilla L, Zitvogel L, Kroemer G. The secret ally: immunostimulation by anticancer drugs. Nat Rev Drug Discov. 2012 Feb 3;11(3):215-33.
  • Galluzzi L, Kepp O, Kroemer G. Mitochondria: master regulators of danger signaling. Nat Rev Mol Cell Biol. 2012 Nov23;13(12):780-8.
  • Kroemer G, Galluzzi L, Kepp O, Zitvogel L. Immunogenic cell death in cancer therapy. Annu Rev Immunol. 2013 Mar 21;31:51-72.
  • Galluzzi L, Kepp O, Vander Heiden M, Kroemer G. Metabolic targets for cancer therapy. Nat Rev Drug Discov. 2013 Nov;12(11):829-46.
  • Marino G, Niso-Santano M, Baerecke EH, Kroemer G. Self-consumption: the interplay of autophagy and apoptosis. Nat Rev Mol Cell Biol. 2014 Feb;15(2):81-94.
  • Madeo F, Pietrocola F, Eisenberg T, Kroemer G. Caloric restriction mimetics: towards a molecular definition. Nat Rev Drug Discov. 2014 Oct;13(10):727-40.
  • Zitvogel L, Galluzzi L, Smyth M, Kroemer G. Type I interferons in anticancer immunity. Nat Rev Immunol. 2015 Jul;15(7):405-14.
  • Zitvogel L, Rusakiewicz S, Routy B, Ayyoub M, Kroemer G. Immunological off-target effects of imatinib. Nat Rev Clin Oncol. 2016 Jul;13(7):431-46.
  • Galluzzi L, Blomgren K, Kroemer G. Autophagy in acute brain damage. Nat Rev Neurosci. 2016 Aug;17(8):467-84.
  • Zitvogel L, J Pitt, Smyth MJ, Kroemer G. Mouse models for oncoimmunology. Nat Rev Cancer. 2016 Dec;16(12):759-773
  • Galluzzi L, Kepp O, Zitvogel L, Kroemer G. Cell death and tumor immunity. Nat Rev Immunol. In press
  • Galluzzi L, Bravo-San Pedro J, Demaria S, Formenti S, Kroemer G. Activating autophagy for immunogenic cancer therapy. Nat Rev Clin Oncol. In press
  • Galluzzi L, Kepp O, Chan FKM, Kroemer G. Necroptosis: mechanisms and relevance to disease. Annual Review of Pathology: Mechanisms of Disease. In press
  • Galluzzi L, Bravo-San Pedro JM, Levine B, Green DR, Kroemer G. Pharmacological modulation of autophagy: Therapeutic potential and persisting obstacles. Nat Rev Drug Discov. In press


14

14

14 

14

14

14

14

14

14

14

 

among others